Aqueous cholecalciferol injection offers a unique solution with rapid correction of vitamin D deficiency in a short span of time
Cadila Pharma has announced the launch of the world’s first aqueous formulation of cholecalciferol for vitamin D deficiency. This innovation demonstrates superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to traditional oil-based cholecalciferol preparations available in the market.
Company’s innovative aqueous cholecalciferol injection offers a unique solution with rapid correction of vitamin D deficiency in a short span of time. This breakthrough not only enhances the efficacy of treatment but also ensures a painless and easy administration process, marking a significant advancement in patient care.
The novel aqueous formulation demonstrates significant improvements in both pharmacokinetic and pharmacodynamics properties of the drug , outperforming conventional oil-based cholecalciferol preparations.
Patients can benefit from a swift correction of vitamin D deficiency in short span of time, addressing a critical need for expedited treatment outcomes in many major illnesses. The injection is designed for ease of use, providing a painless experience for patients, promoting better compliance with treatment regimens.
Dr Rajiv I. Modi, Chairman and Managing Director, Cadila Pharmaceuticals, stated, “Our commitment to innovation and patient centric research to bridge the gap in areas of unmet medical need has driven the development of this ground-breaking aqueous cholecalciferol injection. We believe this advancement will redefine the landscape of Vitamin D deficiency treatment and ensure better treatment outcomes,”
Dr Vijayesh Gupta , COO- BSBU, Cadila Pharmaceuticals, added, “With the launch of the world’s first aqueous Vitamin D injection, Cadila Pharmaceuticals reaffirms its dedication to providing cutting-edge healthcare solutions. We anticipate this innovation will help clinicians to better design their treatment protocols for Vitamin D deficient patients and a large number of patients will benefit from the next generation, world’s first aqueous injectable Vitamin D.”